Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) Return on Sales (2016 - 2020)

Historic Return on Sales for Syndax Pharmaceuticals (SNDX) over the last 7 years, with Q3 2021 value amounting to 52.26%.

  • Syndax Pharmaceuticals' Return on Sales rose 1200.0% to 52.26% in Q3 2021 from the same period last year, while for Sep 2021 it was 52.26%, marking a year-over-year decrease of 89100.0%. This contributed to the annual value of 13.45% for FY2024, which is N/A changed from last year.
  • Syndax Pharmaceuticals' Return on Sales amounted to 52.26% in Q3 2021, which was up 1200.0% from 52.32% recorded in Q2 2021.
  • Over the past 5 years, Syndax Pharmaceuticals' Return on Sales peaked at 15.95% during Q4 2017, and registered a low of 52.38% during Q3 2020.
  • For the 5-year period, Syndax Pharmaceuticals' Return on Sales averaged around 44.54%, with its median value being 47.07% (2018).
  • In the last 5 years, Syndax Pharmaceuticals' Return on Sales surged by 197000bps in 2017 and then plummeted by -349300bps in 2018.
  • Syndax Pharmaceuticals' Return on Sales (Quarter) stood at 15.95% in 2017, then crashed by -219bps to 50.88% in 2018, then grew by 27bps to 37.38% in 2019, then tumbled by -40bps to 52.26% in 2020, then changed by 0bps to 52.26% in 2021.
  • Its Return on Sales stands at 52.26% for Q3 2021, versus 52.32% for Q2 2021 and 49.49% for Q1 2021.